Victor Gurewich MD
Cardiology
Professor of Medicine, Mt. Auburn Hospital
Join to View Full Profile
300 Mount Auburn St305Cambridge, MA 02138
Phone+1 617-661-0567
Fax+1 617-876-0524
Dr. Gurewich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston VA Healthcare System (Brockton-West Roxbury)Fellowship, Cardiovascular Disease, 1960 - 1961
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1959 - 1960- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1956 - 1957
- Beth Israel Deaconess Medical CenterInternship, Transitional Year, 1955 - 1956
Harvard Medical SchoolClass of 1955
Certifications & Licensure
MA State Medical License 1960 - 2023
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Reperfusion of ischemia in the heart or brain.Victor Gurewich, David Segarnick
The Journal of Pharmacology and Experimental Therapeutics. 2025-03-01 - Fibrinolysis Was Replaced before It Was Understood.Victor Gurewich, David Segarnick
Cardiology. 2024-11-04 - 6 citationsDual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase...Nadinda A M van der Ende, Bob Roozenbeek, Lucas E M Smagge, Sven P R Luijten, Leo A M Aerden
Trials. 2022-08-09
Press Mentions
FDA Gives Clearance for Drug to Treat Thrombotic DiseasesSeptember 24th, 2024- Thrombolytic Science Granted US Patent on Novel Clot Dissolving Therapy, Complementing Patent Protection in Europe, Japan, China, Hong Kong, Mexico & CISOctober 29th, 2021
TSI Reports Enrollment of First 10 Patients in Its Phase 2 Ischemic Stroke Clinical Trial and Completion of Its Phase 2 Study Protocol in Myocardial InfarctionOctober 30th, 2019- Join now to see all
Grant Support
- Purification And Properties Of High Affinity UrokinaseNational Heart, Lung, And Blood Institute1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
